1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
AxoGen, Inc.

AxoGen, Inc.

AXGN
AxoGen, Inc.US flagNASDAQ Capital Market
48.28
USD
+1.18
- -
2.60BMarket Cap

Total Valuation

AxoGen, Inc. carries a market capitalization of 2.60B, placing it among publicly traded companies globally. Its enterprise value stands at 2.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.60B
Enterprise Value2.36B

Share Statistics

AxoGen, Inc. currently has 53.18M shares outstanding.

Shares Outstanding53.18M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 9.12, and the price-to-book ratio stands at 9.59.

PE RatioN/A
PS Ratio9.12
PB Ratio9.59
P/TBV Ratio9.88
P/FCF Ratio98.39
P/OCF Ratio152.22

Enterprise Valuation

On an enterprise value basis, AxoGen, Inc. trades at an EV/EBITDA multiple of 2,458.85 and an EV/FCF ratio of 85.21. The EV/Sales ratio of 9.42 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 216.97 provides insight into valuation relative to core operating earnings.

EV / Sales9.42
EV / EBITDA2,458.85
EV / EBIT216.97
EV / FCF85.21

Financial Position

AxoGen, Inc. maintains a current ratio of 6.60, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.83, indicating elevated leverage, while an interest coverage ratio of -0.90 demonstrates limited ability to service its debt obligations.

Current Ratio6.60
Quick Ratio4.79
Debt / Equity7.83
Debt / EBITDA-5.33
Interest Coverage-0.90

Financial Efficiency

Return on Equity (ROE)-18.21
Return on Assets (ROA)-13.15
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)7.51
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.52

Stock Price Statistics

AxoGen, Inc.'s stock has gained approximately 200.99751% over the past 52 weeks. The 50-day moving average sits at 45.19, while the 200-day moving average is 37.55.

Beta (5Y)N/A
52-Week Price Change200.99751%
50-Day Moving Average45.19
200-Day Moving Average37.55
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, AxoGen, Inc. generated 251.17M in revenue and converted that into -33.55M in net income, yielding earnings per share of -0.67. EBITDA reached -3.76M, while operating income came in at -12.85M.

Revenue251.17M
Gross Profit187.27M
Operating Income-12.85M
Pretax Income-33.55M
Net Income-33.55M
EBITDA-3.76M
EBIT-12.85M
Earnings Per Share (EPS)-0.67

Balance Sheet

AxoGen, Inc. holds 111.41M in cash and equivalents against 20.07M in total debt, resulting in a net debt position of -94.57M. Total book value stands at 256.26M, with working capital of 170.00M providing operational flexibility.

Cash & Cash Equivalents111.41M
Total Debt20.07M
Net Debt-94.57M
Equity (Book Value)256.26M
Book Value Per Share4.82
Working Capital170.00M

Cash Flow

AxoGen, Inc. produced 15.05M in operating cash flow over the past twelve months. After subtracting -8.54M in capital expenditures, free cash flow totaled 6.51M - equivalent to 0.13 per share.

Operating Cash Flow15.05M
Capital Expenditures-8.54M
Free Cash Flow6.51M
FCF Per Share0.13

Margins

AxoGen, Inc. operates with a gross margin of 74.56, reflecting its pricing power and cost economics. The operating margin of -5.12 and net profit margin of -13.36 provide insight into operational efficiency.

Gross Margin74.56
Operating Margin-5.12
Pretax Margin-13.36
Profit Margin-13.36
EBITDA Margin-1.50

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-2.88
FCF Yield1.02

Stock Splits

AxoGen, Inc.'s most recent stock split took place on July 11, 1994 with a 20:21 split ratio.

Last Split Date7/11/1994
Split Ratio20:21

Scores

AxoGen, Inc. posts an Altman Z-Score of 30.16, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score30.16